Tobacco use remains the leading preventable cause of death worldwide. In particular, people with mental illness are disproportionately affected with high smoking prevalence; they account for more than 200,000 of the 520,000 tobacco-attributable deaths in the United States annually and die on average 25 years prematurely. Our review aims to provide an update on smoking in the mentally ill. We review the determinants of tobacco use among smokers with mental illness, presented with regard to the public health HAVE framework of “the host” (e.g., tobacco user characteristics), the “agent” (e.g., nicotine product characteristics), the “vector” (e.g., tobacco industry), and the “environment” (e.g., smoking policies). Furthermore, we identify the significant health harms incurred and opportunities for prevention and intervention within a health care systems and larger health policy perspective. A comprehensive effort is warranted to achieve equity toward the 2025 Healthy People goal of reducing US adult tobacco use to 12%, with attention to all subgroups, including smokers with mental illness.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. 1. AAMC (Assoc. Am. Med. Coll.) 2007. Physician Behavior and Practice Patterns Related to Smoking Cessation Washington, DC: AAMC
  2. Acton GS, Prochaska JJ, Kaplan AS, Small T, Hall SM. 2.  2001. Depression and stages of change for smoking in psychiatric outpatients. Addict. Behav. 26:621–31 [Google Scholar]
  3. Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R. 3.  et al. 2013. Electronic nicotine delivery systems: international tobacco control four-country survey. Am. J. Prev. Med. 44:207–15 [Google Scholar]
  4. 4. AHRQ (Agency Healthc. Res. Quality) 2016. Medical Expenditure Panel Survey: table 3: total expenses and percent distribution for selected conditions by type of service: United States, 2013 AHRQ, Rockville, MD. https://meps.ahrq.gov/data_stats/tables_compendia_hh_interactive.jsp?_SERVICE=MEPSSocket0&_PROGRAM=MEPSPGM.TC.SAS&File=HCFY2013&Table=HCFY2013_CNDXP_C&_Debug=
  5. Allen MH, Debanne M, Lazignac C, Adam E, Dickinson LM, Damsa C. 5.  2011. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. Am. J. Psychiatry 168:395–99 [Google Scholar]
  6. 6. Am. Lung Assoc 2016. Affordable Care Act tobacco cessation guidance toolkit Am. Lung Assoc. Chicago: http://www.lung.org/our-initiatives/tobacco/cessation-and-prevention/affordable-care-act-tobacco.html
  7. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T. 7.  et al. 2016. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 387:2507–20 [Google Scholar]
  8. 8. APA (Am. Psychiatr. Assoc.) Workgr. Subst. Use Disord. 2006. Practice Guideline for the Treatment of Patients with Substance Use Disorders. Washington, DC: APA, 2nd ed..
  9. Arnott D, Wessely S, Fitzpatrick M. 9.  2015. Should psychiatric hospitals completely ban smoking?. BMJ 351:h5654 [Google Scholar]
  10. Arrazola RA, Singh T, Corey CG, Husten CG, Neff LJ. 10.  et al. 2015. Tobacco use among middle and high school students—United States, 2011–2014. MMWR 64:381–85 [Google Scholar]
  11. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. 11.  2004. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol. Rev. 111:33–51 [Google Scholar]
  12. Balbuena L, Tempier R. 12.  2015. Independent association of chronic smoking and abstinence with suicide. Psychiatr. Serv. 66:186–92 [Google Scholar]
  13. Bandiera FC, Arheart KL, Caban-Martinez AJ, Fleming LE, McCollister K. 13.  et al. 2010. Secondhand smoke exposure and depressive symptoms. Psychosom. Med. 72:68–72 [Google Scholar]
  14. Bandiera FC, Caban-Martinez AJ, Arheart KL, Davila EP, Fleming LE. 14.  et al. 2010. Secondhand smoke policy and the risk of depression. Ann. Behav. Med. 39:198–203 [Google Scholar]
  15. Bandiera FC, Richardson AK, Lee DJ, He JP, Merikangas KR. 15.  2011. Secondhand smoke exposure and mental health among children and adolescents. Arch. Pediatr. Adolesc. Med. 165:332–38 [Google Scholar]
  16. Barnett PG, Jeffers A, Smith MW, Chow BK, McFall M, Saxon AJ. 16.  2015. Cost-effectiveness of integrating tobacco cessation into post-traumatic stress disorder treatment. Nicotine Tob. Res. 18:267–74 [Google Scholar]
  17. Barnett PG, Wong W, Hall S. 17.  2008. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression. Addiction 103:834–40 [Google Scholar]
  18. Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ. 18.  2015. Cost effectiveness of smoking cessation treatment initiated during psychiatric hospitalization. J. Clin. Psychiatry 76:e1285–91 [Google Scholar]
  19. Bowden JA, Miller CL, Hiller JE. 19.  2011. Smoking and mental illness: a population study in South Australia. Aust. N. Z. J. Psychiatry 45:325–31 [Google Scholar]
  20. Breslau N, Novak SP, Kessler RC. 20.  2004. Daily smoking and the subsequent onset of psychiatric disorders. Psychol. Med. 34:323–33 [Google Scholar]
  21. Breslau N, Schultz LR, Johnson EO, Peterson EL, Davis GC. 21.  2005. Smoking and the risk of suicidal behavior: a prospective study of a community sample. Arch. Gen. Psychiatry 62:328–34 [Google Scholar]
  22. Brown-Johnson CG, Cataldo JK, Orozco N, Lisha NE, Hickman NJ 3rd, Prochaska JJ. 22.  2015. Validity and reliability of the internalized stigma of smoking inventory: an exploration of shame, isolation, and discrimination in smokers with mental health diagnoses. Am. J. Addict. 24:410–18 [Google Scholar]
  23. Brown-Johnson CG, Sanders-Jackson A, Prochaska JJ. 23.  2014. Online comments on smoking bans in psychiatric hospitals units. J. Dual Diagn. 10:204–11 [Google Scholar]
  24. Businelle MS. 24.  2014. The potential of mHealth for tobacco dependence treatment: domestic and international examples from NCI's Smokefree.gov initiative. Nicotine Tob. Res. 16:1033 [Google Scholar]
  25. Cahill K, Stevens S, Perera R, Lancaster T. 25.  2013. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst. Rev. 5:CD009329 [Google Scholar]
  26. Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C. 26.  et al. 2014. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J. Psychiatr. Res. 48:102–10 [Google Scholar]
  27. Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P. 27.  et al. 2015. Smoking and mortality—beyond established causes. N. Engl. J. Med. 372:631–40 [Google Scholar]
  28. 28. CDC (Cent. Dis. Control Prev.) 2011. Quitting smoking among adults—United States 2001–2010. MMWR 60:1513–19 [Google Scholar]
  29. 29. CDC (Cent. Dis. Control Prev.) 2013. Vital signs: current cigarette smoking among adults aged >/=18 years with mental illness—United States, 2009–2011. MMWR 62:81–87 [Google Scholar]
  30. 30. CDC (Cent. Dis. Control Prev.) 2016. Tips from former smokers: Rebecca's story Last updated Jan. 20. CDC, Atlanta. http://www.cdc.gov/tobacco/campaign/tips/stories/rebecca.html
  31. Chapman S. 31.  2013. Should electronic cigarettes be as freely available as tobacco cigarettes? No.. BMJ 346:f3840 [Google Scholar]
  32. Clarke DE, Eaton WW, Petronis KR, Ko JY, Chatterjee A, Anthony JC. 32.  2010. Increased risk of suicidal ideation in smokers and former smokers compared to never smokers: evidence from the Baltimore ECA follow-up study. Suicide Life Threat. Behav. 40:307–18 [Google Scholar]
  33. Colton CW, Manderscheid RW. 33.  2006. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 3:A42 [Google Scholar]
  34. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. 34.  2014. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA 311:172–82 [Google Scholar]
  35. Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C. 35.  2002. Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969–1993. Am. J. Epidemiol. 155:1088–95 [Google Scholar]
  36. Das S, McDonald C, Karan L. 36.  2016. Minimum insurance benefits for patients with nicotine and tobacco use disorder Adopted on May 19, Calif. Soc. Addict. Med., San Francisco. http://csam-asam.org/sites/default/files/pdf/misc/csam-insurance_benefits_tobacco_2016-approved.pdf
  37. Das S, Tonelli M, Ziedonis D. 37.  2016. Update on smoking cessation: e-cigarettes, emerging tobacco products trends, and new technology-based interventions. Curr. Psychiatry Rep. 18:51 [Google Scholar]
  38. de Leon J, Diaz FJ. 38.  2005. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76:135–57 [Google Scholar]
  39. Dockrell M, Morrison R, Bauld L, McNeill A. 39.  2013. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob. Res. 15:1737–44 [Google Scholar]
  40. Eriksen M, Mackay J, Schluger N, Islami F, Drope J. 40.  2015. The Tobacco Atlas Atlanta: Am. Cancer Soc., 5th ed..
  41. Etter J-F. 41.  2013. Should electronic cigarettes be as freely available as tobacco? Yes. BMJ 346:f3845 [Google Scholar]
  42. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL. 42.  et al. 2008. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: Public Health Serv., US Dep. Health Hum. Serv.
  43. Fu SS, McFall M, Saxon AJ, Beckham JC, Carmody TP. 43.  et al. 2007. Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob. Res. 9:1071–84 [Google Scholar]
  44. Gardiner PS. 44.  2004. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res 6:Suppl. 1S55–65 [Google Scholar]
  45. Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW Jr.. 45.  2012. Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. J. Gen. Intern. Med. 27:351–60 [Google Scholar]
  46. Giovino GA, Biener L, Hartman AM, Marcus SE, Schooley MW. 46.  et al. 2009. Monitoring the tobacco use epidemic I. Overview: optimizing measurement to facilitate change. Prev. Med. 48:S4–10 [Google Scholar]
  47. Glanz K, Sutton NM, Jacob Arriola KR. 47.  2006. Operation storefront Hawaii: tobacco advertising and promotion in Hawaii stores. J. Health Commun. 11:699–707 [Google Scholar]
  48. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A. 48.  et al. 2014. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 23:133–39 [Google Scholar]
  49. Goniewicz ML, Lingas EO, Hajek P. 49.  2013. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an Internet survey. Drug Alcohol Rev 32:133–40 [Google Scholar]
  50. Goodman E, Capitman J. 50.  2000. Depressive symptoms and cigarette smoking among teens. Pediatrics 106:748–55 [Google Scholar]
  51. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. 51.  2004. Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 61:1107–15 [Google Scholar]
  52. Haar MV. 52.  2016. Nielsen: E-cig sales growth continues to decline segment is down, despite strong showing from Vuse. CSP Magazine Feb. 3. http://www.cspdailynews.com/category-news/tobacco/articles/nielsen-e-cig-sales-growth-continues-decline
  53. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. 53.  1999. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch. Intern. Med. 159:2033–38 [Google Scholar]
  54. Hall SM, Prochaska JJ. 54.  2009. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu. Rev. Clin. Psychol. 5:409–31 [Google Scholar]
  55. Harris AE. 55.  1988. Physical disease and schizophrenia. Schizophr. Bull. 14:85–96 [Google Scholar]
  56. Hebert KK, Cummins SE, Hernández S, Tedeschi GJ, Zhu SH. 56.  2011. Current major depression among smokers using a state quitline. Am. J. Prev. Med. 40:47–53 [Google Scholar]
  57. Hefner K, Rosenheck R, Merrel J, Coffman M, Valentine G, Sofuoglu M. 57.  2016. E-cigarette use in veterans seeking mental health and/or substance use services. J. Dual Diagn. 12:109–17 [Google Scholar]
  58. Hickman NJ 3rd, Delucchi KL, Prochaska JJ. 58.  2014. Menthol use among smokers with psychological distress: findings from the 2008 and 2009 National Survey on Drug Use and Health. Tob. Control 23:7–13 [Google Scholar]
  59. Hickman NJ 3rd, Delucchi KL, Prochaska JJ. 59.  2015. Treating tobacco dependence at the intersection of diversity, poverty, and mental illness: a randomized feasibility and replication trial. Nicotine Tob. Res. 17:1012–21 [Google Scholar]
  60. Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. 60.  2004. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am. J. Psychiatry 161:2317–19 [Google Scholar]
  61. Hwang SL, Ono Y. 61.  1995. Tobacco dream team: experts who insist nicotine isn't addictive. Wall Street Journal March 23. http://www.apnewsarchive.com/1995/Tobacco-Dream-Team-Experts-Who-Insist-Nicotine-Isn-t-Addictive/id-5e11991ee5bf4faf852b22b1eeeace1f
  62. Jamal A, Homa DM, O'Connor E, Babb SD, Caraballo RS. 62.  et al. 2015. Current cigarette smoking among adults—United States, 2005–2014. MMWR 64:1233–40 [Google Scholar]
  63. Kahler CW, Spillane NS, Busch AM, Leventhal AM. 63.  2011. Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment. Nicotine Tob. Res. 13:146–50 [Google Scholar]
  64. Kandel DB, Kandel ER. 64.  2014. A molecular basis for nicotine as a gateway drug. N. Engl. J. Med. 371:2038–39 [Google Scholar]
  65. King BA, Alam S, Promoff G, Arrazola R, Dube SR. 65.  2013. Awareness and ever-use of electronic cigarettes among U.S. adults, 2010–2011. Nicotine Tob. Res. 15:1623–27 [Google Scholar]
  66. Klungsoyr O, Nygard JF, Sorensen T, Sandanger I. 66.  2006. Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am. J. Epidemiol. 163:421–32 [Google Scholar]
  67. Knott V. 67.  1983. Tobacco smoking as a coping mechanism in psychiatric patients: psychological, behavioral and physiological investigations phase I April 18, Philip Morris. Bates No. 1002647660/7696. http://legacy.library.ucsf.edu/tid/twb64e00
  68. Kofman M, Dunton K, Senkewicz MB. 68.  2012. Implementation of Tobacco Cessation Coverage Under the Affordable Care Act: Understanding How Private Health Insurance Policies Cover Tobacco Cessation Treatments Washington, DC: Georgetown Univ. Health Policy Inst. http://www.tobaccofreekids.org/pressoffice/2012/georgetown/coveragereport.pdf
  69. Krebs P, Rogers E, Smelson D, Fu S, Wang B, Sherman S. 69.  2016. Relationship between tobacco cessation and mental health outcomes in a tobacco cessation trial. J. Health Psychol. In press. https://doi.org/10.1177/1359105316644974
  70. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. 70.  2000. Smoking and mental illness: a population-based prevalence study. JAMA 284:2606–10 [Google Scholar]
  71. Lawn S, Campion J. 71.  2013. Achieving smoke-free mental health services: lessons from the past decade of implementation research. Int. J. Environ. Res. Public Health 10:4224–44 [Google Scholar]
  72. Lawn S, Pols R. 72.  2005. Smoking bans in psychiatric inpatient settings? A review of the research. Aust. N. Z. J. Psychiatry 39:866–85 [Google Scholar]
  73. Lawn SJ. 73.  2004. Systemic barriers to quitting smoking among institutionalised public mental health service populations: a comparison of two Australian sites. Int. J. Soc. Psychiatry 50:204–15 [Google Scholar]
  74. Lawrence D, Hancock KJ, Kisely S. 74.  2013. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 346:f2539 [Google Scholar]
  75. Lawrence D, Mitrou F, Zubrick SR. 75.  2009. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 9:285 [Google Scholar]
  76. Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. 76.  2001. Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry 58:573–78 [Google Scholar]
  77. Lincoln JE. 77.  1983. Schizophrenics June 29, Philip Morris. Bates No. 1005062041/2042. http://legacy.library.ucsf.edu/tid/yrt53e00
  78. McClave AK, McKnight-Eily LR, Davis SP, Dube SR. 78.  2010. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am. J. Public Health 100:2464–72 [Google Scholar]
  79. McDermott MS, Marteau TM, Hollands GJ, Hankins M, Aveyard P. 79.  2013. Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study. Br. J. Psychiatry 202:62–67 [Google Scholar]
  80. McFall M, Saxon AJ, Malte CA, Chow B, Bailey S. 80.  et al. 2010. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA 304:2485–93 [Google Scholar]
  81. Metse AP, Wiggers J, Wye P, Wolfenden L, Prochaska JJ. 81.  et al.2017 Smoking and mental illness: a bibliometric analysis of research output over time. Nicotine Tob. Res. 1924–31
  82. Mills AL, Messer K, Gilpin EA, Pierce JP. 82.  2009. The effect of smoke-free homes on adult smoking behavior: a review. Nicotine Tob. Res. 11:1131–41 [Google Scholar]
  83. Nahvi S, Richter K, Li X, Modali L, Arnsten J. 83.  2006. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict. Behav. 31:2127–34 [Google Scholar]
  84. Ong MK, Zhou Q, Sung HY. 84.  2010. Sensitivity to cigarette prices among individuals with alcohol, drug, or mental disorders. Am. J. Public Health 100:1243–45 [Google Scholar]
  85. Oquendo MA, Galfalvy H, Russo S, Ellis SP, Grunebaum MF. 85.  et al. 2004. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am. J. Psychiatry 161:1433–41 [Google Scholar]
  86. Orleans CT, Slade J. 86.  1993. Nicotine Addiction: Principles and Management New York: Oxford Univ. Press
  87. Potkin SG, Alphs L, Hsu C, Krishnan KR, Anand R. 87.  et al. 2003. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol. Psychiatry 54:444–52 [Google Scholar]
  88. Prochaska JJ. 88.  2010. Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?. Drug Alcohol Depend 110:177–82 [Google Scholar]
  89. Prochaska JJ, Benowitz NL. 89.  2016. The past, present, and future of nicotine addiction therapy. Annu. Rev. Med. 67:467–86 [Google Scholar]
  90. Prochaska JJ, Delucchi K, Hall SM. 90.  2004. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J. Consult. Clin. Psychol. 72:1144–56 [Google Scholar]
  91. Prochaska JJ, Fletcher L, Hall SE, Hall SM. 91.  2006. Return to smoking following a smoke-free psychiatric hospitalization. Am. J. Addict. 15:15–22 [Google Scholar]
  92. Prochaska JJ, Fromont SC, Leek D, Hudmon KS, Louie AK. 92.  et al. 2008. Evaluation of an evidence-based tobacco treatment curriculum for psychiatry residency training programs. Acad. Psychiatry 32:484–92 [Google Scholar]
  93. Prochaska JJ, Fromont SC, Louie AK, Jacobs MH, Hall SM. 93.  2006. Training in tobacco treatments in psychiatry: a national survey of psychiatry residency training directors. Acad. Psychiatry 30:372–78 [Google Scholar]
  94. Prochaska JJ, Grana RA. 94.  2014. E-cigarette use among smokers with serious mental illness. PLOS ONE 9:e113013 [Google Scholar]
  95. Prochaska JJ, Hall SE, Delucchi K, Hall SM. 95.  2014. Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am. J. Public Health 104:1557–65 [Google Scholar]
  96. Prochaska JJ, Hall SM, Bero LA. 96.  2008. Tobacco use among individuals with schizophrenia: What role has the tobacco industry played?. Schizophr. Bull. 34:555–67 [Google Scholar]
  97. Prochaska JJ, Reyes RS, Schroeder SA, Daniels AS, Doederlein A, Bergeson B. 97.  2011. An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disord 13:466–73 [Google Scholar]
  98. Prochaska JJ, Rossi JS, Redding CA, Rosen AB, Tsoh JY. 98.  et al. 2004. Depressed smokers and stage of change: implications for treatment interventions. Drug Alcohol Depend 76:143–51 [Google Scholar]
  99. Proctor RN. 99.  2011. Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition Berkeley: Univ. Calif. Press
  100. 100. R. Coll. Phys., R. Coll. Psychiatr. 2013. Smoking and Mental Health London: R. Coll. Phys.
  101. 101. R. J. Reynolds Tobacco Co 1996. Project Scum. Legacy Tobacco Documents Library. https://www.industrydocumentslibrary.ucsf.edu/tobacco/docs/sfck0098
  102. Rice D. 102.  1979. No lung cancer in schizophrenics?. Br. J. Psychiatry 134:128 [Google Scholar]
  103. Richard P, West K, Ku L. 103.  2012. The return on investment of a Medicaid tobacco cessation program in Massachusetts. PLOS ONE 7:e29665 [Google Scholar]
  104. Rising J, Alexander L. 104.  2011. Marketing of menthol cigarettes and consumer perceptions. Tob. Induc. Dis. 9:Suppl. 1S2 [Google Scholar]
  105. Roberts E, Eden Evins A, McNeill A, Robson D. 105.  2016. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction 111:599–612 [Google Scholar]
  106. Rogers ES, Smelson DA, Gillespie CC, Elbel B, Poole S. 106.  et al. 2016. Telephone smoking-cessation counseling for smokers in mental health clinics: a patient-randomized controlled trial. Am. J. Prev. Med. 50:518–27 [Google Scholar]
  107. Rosecrans JA. 107.  1998. Nicotine: helping those who help themselves?. Chem. Ind. (13):525–29 [Google Scholar]
  108. Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J. 108.  et al. 1998. Sudden death in psychiatric patients. Br. J. Psychiatry 172:331–36 [Google Scholar]
  109. Schacht LM, Ortiz G, Lane GM Jr. 109.  2011. Smoking policies and practices in state psychiatric facilities: survey results from 2011 April, Natl. Assoc. State Mental Health Progr. Dir. Res. Inst. (NRI) Falls Church, VA:
  110. Schauer GL, Malarcher AM, Zhang L, Engstrom MC, Zhu S-H. 110.  2013. Prevalence and correlates of quitline awareness and utilization in the United States: an update from the 2009–2010 National Adult Tobacco Survey. Nicotine Tob. Res. 16:544–53 [Google Scholar]
  111. Schroeder SA, Morris CD. 111.  2010. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu. Rev. Public Health 31:297–314 [Google Scholar]
  112. Severson HH, Akers L, Andrews JA, Lichtenstein E, Jerome A. 112.  2000. Evaluating two self-help interventions for smokeless tobacco cessation. Addict. Behav. 25:465–70 [Google Scholar]
  113. Sheals K, Tombor I, McNeill A, Shahab L. 113.  2016. A mixed-method systematic review and meta-analysis of mental health professionals’ attitudes toward smoking and smoking cessation amongst people with mental illnesses. Addiction 111:1536–53 [Google Scholar]
  114. Siru R, Hulse GK, Tait RJ. 114.  2009. Assessing motivation to quit smoking in people with mental illness: a review. Addiction 104:719–33 [Google Scholar]
  115. Slemmer JE, Martin BR, Damaj MI. 115.  2000. Bupropion is a nicotinic antagonist. J. Pharmacol. Exp. Ther. 295:321–27 [Google Scholar]
  116. Smith PH, Young-Wolff KC, Hyland A, McKee SA. 116.  2014. Are statewide restaurant and bar smoking bans associated with reduced cigarette smoking among those with mental illness?. Nicotine Tob. Res. 16:846–54 [Google Scholar]
  117. Sokal J, Messias E, Dickerson FB, Kreyenbuhl J, Brown CH. 117.  et al. 2004. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J. Nerv. Ment. Dis. 192:421–27 [Google Scholar]
  118. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. 118.  2013. Telephone counselling for smoking cessation. Cochrane Database Syst. Rev. 8:CD002850 [Google Scholar]
  119. Steinberg ML, Williams JM, Stahl NF, Budsock PD, Cooperman NA. 119.  2016. An adaptation of motivational interviewing increases quit attempts in smokers with serious mental illness. Nicotine Tob. Res. 18:243–50 [Google Scholar]
  120. Steinberg ML, Williams JM, Ziedonis DM. 120.  2004. Financial implications of cigarette smoking among individuals with schizophrenia. Tob. Control 13:206 [Google Scholar]
  121. Steuber T, Danner F. 121.  2006. Adolescent smoking and depression: Which comes first?. Addict. Behav. 31:133–36 [Google Scholar]
  122. Stubbs J, Haw C, Garner L. 122.  2004. Survey of staff attitudes to smoking in a large psychiatric hospital. Psychiatr. Bull. 28:204–7 [Google Scholar]
  123. Stuber J, Galea S, Link BG. 123.  2008. Smoking and the emergence of a stigmatized social status. Soc. Sci. Med. 67:420–30 [Google Scholar]
  124. Sung HY, Prochaska JJ, Ong MK, Shi Y, Max W. 124.  2011. Cigarette smoking and serious psychological distress: a population-based study of California adults. Nicotine Tob. Res. 13:1183–92 [Google Scholar]
  125. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. 125.  2014. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 348:g1151 [Google Scholar]
  126. Thomas KH, Martin RM, Knipe DW, Higgins JP, Gunnell D. 126.  2015. Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ 350:h1109 [Google Scholar]
  127. Thurgood SL, McNeill A, Clark-Carter D, Brose LS. 127.  2016. A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine Tob. Res. 18:993–1001 [Google Scholar]
  128. 128. Tob. Prod. Sci. Advis. Comm. 2011. Menthol Cigarettes and Public Health: Review of the Scientific Evidence and Recommendations. Rockville, MD: Food Drug Adm http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/tobaccoproductsscientificadvisorycommittee/ucm269697.pdf
  129. Tsoi DT, Porwal M, Webster AC. 129.  2013. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst. Rev. 2:CD007253 [Google Scholar]
  130. 130. US Dep. Labor. 2014. FAQs about Affordable Care Act implementation (part XIX). May 2, US Dep. Labor Washington, DC: https://www.dol.gov/ebsa/faqs/faq-aca19.html
  131. 131. US DHHS (Dep. Health Hum. Serv.) 1998. Alcohol Alert No. 39, http://pubs.niaaa.nih.gov/publications/AA71/AA71.htm
  132. 132. US DHHS (Dep. Health Hum. Serv.) 2000. Reducing Tobacco Use: A Report of the Surgeon General—Executive Summary Atlanta: US DHHS, Cent. Dis. Control Prev., Natl. Cent. Chronic Dis. Prev. Health Promot., Off. Smok. Health
  133. 133. US DHHS (Dep. Health Hum. Serv.) 2014. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General Atlanta: US DHHS, Cent. Dis. Control Prev., Natl. Cent. Chronic Dis. Prev. Health Promot., Off. Smok. Health
  134. 134. US DHHS (Dep. Health Hum. Serv.), Off. Dis. Prev. Health Promot Healthy People 2020 https://www.healthypeople.gov/2020/topics-objectives/topic/tobacco-use/objectives
  135. Veldhuizen S, Callaghan RC. 135.  2014. Cause-specific mortality among people previously hospitalized with opioid-related conditions: a retrospective cohort study. Ann. Epidemiol. 24:620–24 [Google Scholar]
  136. Warner KE. 136.  1997. Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage. Pharmacoeconomics 11:538–49 [Google Scholar]
  137. Webb Hooper M, Zhao W, Byrne MM, Davila E, Caban-Martinez A. 137.  et al. 2011. Menthol cigarette smoking and health, Florida 2007 BRFSS. Am. J. Health Behav. 35:3–14 [Google Scholar]
  138. Weiser M, Reichenberg A, Grotto I, Yasvitzky R, Rabinowitz J. 138.  et al. 2004. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am. J. Psychiatry 161:1219–23 [Google Scholar]
  139. Windle M, Windle RC. 139.  2001. Depressive symptoms and cigarette smoking among adolescents: prospective associations and intrapersonal and interpersonal influences. J. Consult. Clin. Psychol. 69:215–26 [Google Scholar]
  140. Wye PM, Bowman JA, Wiggers JH, Baker A, Knight J. 140.  et al. 2009. Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia. Psychiatr. Serv. 60:100–7 [Google Scholar]
  141. Yerger VB, Przewoznik J, Malone RE. 141.  2007. Racialized geography, corporate activity, and health disparities: tobacco industry targeting of inner cities. J. Health Care Poor Underserved 18:10–38 [Google Scholar]
  142. Young-Wolff KC, Henriksen L, Delucchi K, Prochaska JJ. 142.  2014. Tobacco retailer proximity and density and nicotine dependence among smokers with serious mental illness. Am. J. Public Health 104:1454–63 [Google Scholar]
  143. Young-Wolff KC, Hickman NJ 3rd, Kim R, Gali K, Prochaska JJ. 143.  2015. Correlates and prevalence of menthol cigarette use among adults with serious mental illness. Nicotine Tob. Res. 17:285–91 [Google Scholar]
  144. Young-Wolff KC, Hickman NJ, Prochaska JJ. 144.  2016. Menthol use in smokers with mental illness: sensory and price preferences. Tob. Regul. Sci. 3:215–26 [Google Scholar]
  145. Young-Wolff KC, Kline-Simon AH, Das S, Mordecai DJ, Miller-Rosales C, Weisner C. 145.  2016. Smoking trends among adults with behavioral health conditions in integrated health care: a retrospective cohort study. Psychiatr. Serv. 67:996–1003 [Google Scholar]
  146. Zevin S, Benowitz NL. 146.  1999. Drug interactions with tobacco smoking. An update. Clin. Pharmacokinet. 36:425–38 [Google Scholar]
  147. Ziedonis D, Das S, Tonelli M. 147.  2015. Smoking and mental illness: strategies to increase screening, assessment & treatment. FOCUS 13:290–306 [Google Scholar]
  148. Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. 148.  1994. Nicotine dependence and schizophrenia. Hosp. Community Psychiatry 45:204–6 [Google Scholar]
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error